Skip to Content

Thermo Fisher Scientific Inc - Stock Quote TMO

Rating as of

Morningstar's Thermo Fisher Scientific Inc Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Strong Start in Core Business for Thermo Fisher in Q1

Alex Morozov, CFA Regional Director

Analyst Note

| Alex Morozov, CFA |

Wide-moat Thermo Fisher Scientific kicked off 2021 with strong results across most segments, allowing the company to materially raise its revenue and earnings guidance for the full year. We are updating our model and expecting a modest raise in our fair value estimate, but we anticipate shares still trading at a premium to our valuation.

Read Full Analysis

Thermo Fisher Scientific Inc's Company Profile

Business Description

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (17%); life science solutions (38%); and lab products and services (38%).

Contact
168 Third Avenue
Waltham, MA, 02451
T +1 781 622-1000
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2022
Stock Type Aggressive Growth
Employees 130,000

Thermo Fisher Scientific Inc's Related Articles & News